The Lovesac Company Total Liabilities
The Lovesac Company total liabilities. Based on the latest financial reports, The Lovesac Company (LOVE) has total liabilities worth $295.44 Million USD as of April 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check financial resilience of The Lovesac Company to evaluate the company's liquid asset resilience ratio.
Total Liabilities of The Lovesac Company (2016–2026)
Total liabilities of The Lovesac Company from 2016 to 2026. This chart illustrates how The Lovesac Company's total liabilities have evolved over time, based on quarterly financial data.
The Lovesac Company Competitors by Total Liabilities
The table below lists competitors of The Lovesac Company ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
AbClon Inc
KQ:174900
|
Korea | ₩11.43 Billion |
|
Mandala Multifinance Tbk
JK:MFIN
|
Indonesia | Rp3.13 Trillion |
|
Columbus Circle Capital Corp III Class A Ordinary Shares
NASDAQ:CCCT
|
USA | $259.27K |
|
Z.M.H Hammerman Ltd
TA:ZMH
|
Israel | ILA1.25 Billion |
|
Hyundai Motor S3 Pref
KO:005389
|
Korea | ₩259.10 Trillion |
|
Sonix Technology Co Ltd
TW:5471
|
Taiwan | NT$833.42 Million |
|
Kodiak AI, Inc. Common Stock
NASDAQ:KDK
|
USA | $160.12 Million |
|
GOLFZON NEWDIN HOLDINGS Co. Ltd
KQ:121440
|
Korea | ₩349.31 Billion |
Liability Composition Analysis (2016–2026)
This chart breaks down The Lovesac Company's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see LOVE current and non-current assets.
Liquidity & Leverage Metrics
The Lovesac Company Total Liabilities Ratios Explained
The Lovesac Company total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.55 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.44 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.59 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how The Lovesac Company's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for The Lovesac Company (2016–2026)
The table below shows the annual total liabilities of The Lovesac Company from 2016 to 2026.
| Year | Total Liabilities | Change |
|---|---|---|
| 2026-01-31 | $315.98 Million | +0.03% |
| 2025-01-31 | $315.89 Million | +19.35% |
| 2024-01-31 | $264.68 Million | +17.75% |
| 2023-01-31 | $224.79 Million | +6.40% |
| 2022-01-31 | $211.27 Million | +234.96% |
| 2021-01-31 | $63.07 Million | +77.62% |
| 2020-01-31 | $35.51 Million | +35.30% |
| 2019-01-31 | $26.24 Million | +47.42% |
| 2018-01-31 | $17.80 Million | +30.23% |
| 2017-01-31 | $13.67 Million | -9.99% |
| 2016-01-31 | $15.19 Million | -- |
About The Lovesac Company
The Lovesac Company designs, manufactures, and sells furniture. It offers sactionals, such as seats and sides; sacs, including foam beanbag chairs; and other products comprising drink holders, footsac blankets, decorative pillows, fitted seat tables, and ottomans. The company also provides StealthTech, a home theater system; and PillowSac, an accent chair. It markets its products primarily throug… Read more